CurrentCardio
Get Weekly

Cardiovascular journalCurrentCardio coverage

Circulation: Cardiovascular Interventions

What CurrentCardio has captured from this journal. The coverage figures describe CurrentCardio's coverage, not the journal's output. Figures as of 13 October 2026.

Recent
19 Briefs
past 90 days
Archive
77 Briefs
research published Jan–Dec 2026 · 1 undated
Editorial
–
no Weekly issue published yet
Impact Factor
7.2
2025 · Journal Citation Reports

Topics

Evidence types

Shares are of the 77 Briefs CurrentCardio has covered from Circ Cardiovasc Interv, by primary topic and study type.

Publication activity

Latest from Circulation: Cardiovascular Interventions

All coverage, newest first

  1. Circ Cardiovasc Interv

    High-Potency P2Y12 Inhibitors Among Patients With Chronic Coronary Syndrome Undergoing PCI: An Analysis From the NCDR CathPCI Registry

    Cohort studyCoronary & ACS

  2. Circ Cardiovasc Interv

    Paclitaxel-Coated Devices in Patients With Chronic Limb-Threatening Ischemia and Tissue Loss Undergoing Infrainguinal Endovascular Revascularization: Insights From the SWEDEPAD-1 Trial

    Secondary analysisAortic & peripheral

  3. Circ Cardiovasc Interv

    Contrasting Prognostic Value of Discordance Between Resting Distal-to-Aortic Coronary Pressure Ratio and Fractional Flow Reserve in Coronary Artery Disease

    Cohort studyCoronary & ACS

  4. Circ Cardiovasc Interv

    Influence of Chronic Kidney Disease on Outcomes After Paclitaxel-Coated Balloon Angioplasty for Coronary In-Stent Restenosis

    Secondary analysisCoronary & ACS

  5. Circ Cardiovasc Interv

    Minicrush or T-Stenting and Minimal Protrusion in Complex Coronary Bifurcation Lesions: The Multicenter TREX Registry

    Cohort studyCoronary & ACS

  6. Circ Cardiovasc Interv

    Impact of Initial Valve Type on Reintervention for TAVR Failure: From the EXPLANTORREDO-TAVR International Registry

    Cohort studyValvular & structural

  7. Circ Cardiovasc Interv

    Impact of Tricuspid Regurgitation on Outcomes After Transcatheter Edge-to-Edge Repair for Primary Mitral Regurgitation: The PRIME-MR Registry

    Cohort studyValvular & structural

  8. Circ Cardiovasc Interv

    Mitral Regurgitation and Severe Aortic Stenosis: Clinical Characteristics, Prognostic Impact, and Response to TAVR: Insights From Egnite Data

    Cohort studyValvular & structural

  9. Circ Cardiovasc Interv

    Contemporary Trends for the Treatment of In-Stent Restenosis in the United States, 2009 to 2024

    Cohort studyCoronary & ACS

  10. Circ Cardiovasc Interv

    Clinical Outcomes of a Dedicated TAVR Device for Native Aortic Regurgitation: Insights From a Multicenter Real-World Experience

    Cohort studyValvular & structural

  11. Circ Cardiovasc Interv

    Accuracy of Angiographic Identification of Culprit Lesions in Women With MINOCA

    Diagnostic or prognostic studyCoronary & ACS

  12. Circ Cardiovasc Interv

    One-Year Outcomes of M-TEER With the PASCAL System in Atrial and Ventricular FMR: Insights From the MiCLASP Postmarket Clinical Follow-Up Study

    Research articleValvular & structural

  13. Circ Cardiovasc Interv

    Bioprosthetic Valve Failure After Transcatheter Aortic Valve Replacement

    Cohort studyValvular & structural

  14. Circ Cardiovasc Interv

    Pulmonary Atresia With Intact Septum Survival, Reintervention, and Days in Hospital Through Childhood: Contemporary Outcomes From a National Registry

    Cohort studyCongenital

  15. Circ Cardiovasc Interv

    Linking the TVT Registry to Medicare Advantage and Fee-for-Service Claims: Feasibility, Accuracy, and Implications for Real-World Surveillance Infrastructure

    Cohort studyValvular & structural

  16. Circ Cardiovasc Interv

    Predictors of Target Lesion Failure in Patients With In-Stent Restenosis: Insights From the AGENT IDE Trial

    Secondary analysisCoronary & ACS

  17. Circ Cardiovasc Interv

    Impact of Coronary Diameter Stenosis and Proximal Lesion Location on Outcomes Following PCI in Patients Undergoing TAVI: Prespecified NOTION-3 Substudy

    Secondary analysisValvular & structural

  18. Circ Cardiovasc Interv

    Temporal Trends and Predictors of Access Site Crossover During PCI in Contemporary Practice: A Report From the NCDR CathPCI Registry

    Cohort studyCoronary & ACS

  19. Circ Cardiovasc Interv

    Antithrombotic Therapy in Patients With Atrial Fibrillation With Prior Complex PCI: A Secondary Analysis of the Randomized ADAPT AF-DES Trial

    Secondary analysisCoronary & ACS

  20. Circ Cardiovasc Interv

    Abbreviated Dual Antiplatelet Therapy in Patients With High Bleeding Risk Undergoing PCI of Bifurcation Lesions: A Prespecified Substudy of the MASTER DAPT Trial

    Secondary analysisCoronary & ACS

  21. Circ Cardiovasc Interv

    Optical Coherence Tomography Characterization of Coronary Lithotripsy Following Atherectomy for Treatment of Severely Calcified Lesions

    Secondary analysisCoronary & ACS

  22. Circ Cardiovasc Interv

    Risk of Aortic Root Rupture in Bicuspid Aortic Stenosis: The ABC Sizing Algorithm for SAPIEN 3 Valves

    Cohort studyValvular & structural

  23. Circ Cardiovasc Interv

    Nicorandil to Prevent Contrast-Associated Kidney Injury in High-Risk PCI

    Randomised controlled trialCoronary & ACS

  24. Circ Cardiovasc Interv

    Prospective Midterm Outcomes of the PULSTA Self-Expandable Transcatheter Pulmonary Valve: The PULSTA CE Approval Study

    Cohort studyValvular & structural

  25. Circ Cardiovasc Interv

    Is There a Golden Hour for Thrombectomy in Intermediate-Risk Pulmonary Embolism? Insights From SYMPHONY-PE

    Research articlePulmonary vascular & VTE

  26. Circ Cardiovasc Interv

    Technical Success of Fetal Aortic Valvuloplasty in Relation to Center Volumes: A Report From the International Fetal Cardiac Intervention Registry

    Cohort studyCongenital

  27. Circ Cardiovasc Interv

    Impact of Revascularization Completeness on Cardiovascular Outcomes in STEMI With Multivessel Disease

    Secondary analysisCoronary & ACS

  28. Circ Cardiovasc Interv

    Age and Procedural Timing for Asymptomatic Severe Aortic Stenosis: Analysis From the EARLY TAVR Trial

    Research articleValvular & structural

  29. Circ Cardiovasc Interv

    Comparison of Drug-Coated Versus Conventional Balloons for the Side Branches of Bifurcation Lesions: OCVC-BIF Study

    Randomised controlled trialCoronary & ACS

  30. Circ Cardiovasc Interv

    Impact of Intravascular Imaging on Clinical Outcomes in Focal Versus Diffuse Coronary Artery Disease

    Cohort studyCoronary & ACS

  31. Circ Cardiovasc Interv

    Clinical Impact of Myocardium at Risk in Transcatheter Aortic Valve Implantation

    Cohort studyValvular & structural

  32. Circ Cardiovasc Interv

    Angiography-Derived FFR Versus IVUS to Guide PCI According to Angiographic Lesion Characteristics

    Secondary analysisCoronary & ACS

  33. Circ Cardiovasc Interv

    Measured Versus Predicted Prosthesis–Patient Mismatch after TAVR in Sievers Type 1 BAV: Incidence, Determinants, and Outcomes From the AD-HOC Registry

    Cohort studyValvular & structural

  34. Circ Cardiovasc Interv

    Use of Paclitaxel-Coated Balloons in the United States: Early Results From the AGENT Postapproval Study

    Cohort studyCoronary & ACS

  35. Circ Cardiovasc Interv

    Clinical Experience With a Novel Percutaneous LV Assist Device in High-Risk PCI: Primary Results From the SUPPORT I Study

    Cohort studyCoronary & ACS

  36. Circ Cardiovasc Interv

    One-Year Outcomes of Screen Failures for Transcatheter Tricuspid Valve Repair: Insights From the TriSelect Study

    Cohort studyValvular & structural

  37. Circ Cardiovasc Interv

    Postapproval Study Outcomes of Muscular Ventricular Septal Defect Closure With the Amplatzer Muscular VSD Occluder

    Research articleCongenital

  38. Circ Cardiovasc Interv

    Clinical Outcomes of Bail-Out Stenting After Drug-Coated Balloon Angioplasty: The International Multicenter BAILOUT Registry

    Cohort studyCoronary & ACS

  39. Circ Cardiovasc Interv

    Systematic Ambulatory ECG Monitoring for Preventing Life-Threatening Cardiovascular Events Following TAVR

    Cohort studyValvular & structural

  40. Circ Cardiovasc Interv

    Timing of Complete Revascularization in Patients With STEMI and Multivessel Disease: An Updated Meta-Analysis of Randomized Clinical Trials

    Meta-analysisCoronary & ACS

All 77 Briefs in ExploreShowing the 40 most recently published